Metaz 0.1 cream topical corticosteroid

Generic Name: Mometasone Furoate
Trade Name: Metaz Cream 0 1%
Strength value: /%
Dosage Form: Cream
Route of Administration: Topical
ATC Code: D07AC13
Volume: 30/g
Package type: Tube
Package size: 1
Legal status: Prescription
Product control: Uncontrolled
Shelf-life (mon): 36
Storage conditions: Store below 25°C
Manufacturer Name: Spimaco
Country Of Manufacturer: Saudi Arabia
Marketing Company: Spimaco
Nationality: Saudi Arabia
Medicinal products with same active substance:
•Avocom
•Avocom
•Avocom 0 05% Aqueous Nasal Spray
•Eczaderm 0 1% W-W Cream
•Eczaderm 0 1% W-W Ointment
•Elica 0 1% Cream
•Elica 0 1% Ointment
•Elna 0 1% W-W Cream
•Elocom 0 1% Cream
•Elocom 0 1% Lotion
•Elocom 0 1% Ointment
•Metaz Lotion 0 1%
•Metaz 0 1% W-W Ointment
•Metaz 0 1% W-W Ointment
•Metaz Cream 0 1%
•Mometamed 0 1% W-W Cream
•Momiderm Cream 30G
•Momiderm Ointment 30 G
•Nasonex 0 05% Nasal Spray
•Tabunex 0 05% Nasal Spray
•Zynovate 0 1% Cream
•Zynovate 0 1% Cream
•Zynovate 0 1% Ointment
•Zynovate 0 1% Ointment
•Elica-M Cream
•Elicasal Ointment

Generic Name: Mometasone Furoate
Trade Name: Metaz 0 1% W-W Ointment
Strength value: /%
Dosage Form: Ointment
Route of Administration: Topical
ATC Code: D07AC13
Volume: 30/g
Package type: Tube
Package size: 1
Legal status: Prescription
Product control: Uncontrolled
Shelf-life (mon): 36
Storage conditions: Store below 25°C
Manufacturer Name: Spimaco
Country Of Manufacturer: Saudi Arabia
Marketing Company: Spimaco
Nationality: Saudi Arabia
Medicinal products with same active substance:
•Avocom
•Avocom
•Avocom 0 05% Aqueous Nasal Spray
•Eczaderm 0 1% W-W Cream
•Eczaderm 0 1% W-W Ointment
•Elica 0 1% Cream
•Elica 0 1% Ointment
•Elna 0 1% W-W Cream
•Elocom 0 1% Cream
•Elocom 0 1% Lotion
•Elocom 0 1% Ointment
•Metaz Lotion 0 1%
•Metaz 0 1% W-W Ointment
•Metaz 0 1% W-W Ointment
•Metaz Cream 0 1%
•Mometamed 0 1% W-W Cream
•Momiderm Cream 30G
•Momiderm Ointment 30 G
•Nasonex 0 05% Nasal Spray
•Tabunex 0 05% Nasal Spray
•Zynovate 0 1% Cream
•Zynovate 0 1% Cream
•Zynovate 0 1% Ointment
•Zynovate 0 1% Ointment
•Elica-M Cream
•Elicasal Ointment

In controlled clinical trials involving 319 subjects, the incidence of adverse reactions associated with the use of Mometasone Furoate Cream % was %. Reported reactions included burning, pruritus, and skin atrophy. Reports of rosacea associated with the use of Mometasone Furoate Cream % have also been received. In controlled clinical trials (n=74) involving pediatric subjects 2 to 12 years of age, the incidence of adverse experiences associated with the use of Mometasone Furoate Cream % was approximately 7%. Reported reactions included stinging, pruritus, and furunculosis.

The following adverse reactions were reported to be possibly or probably related to treatment with Mometasone Furoate Cream % during clinical trials in 4% of 182 pediatric subjects 6 months to 2 years of age: decreased glucocorticoid levels, 2; paresthesia, 2; folliculitis, 1; moniliasis, 1; bacterial infection, 1; skin depigmentation, 1. The following signs of skin atrophy were also observed among 97 subjects treated with Mometasone Furoate Cream % in a clinical trial: shininess, 4; telangiectasia, 1; loss of elasticity, 4; loss of normal skin markings, 4; thinness, 1; and bruising, 1.

Metaz 0.1 cream topical corticosteroid

metaz 0.1 cream topical corticosteroid

Media:

metaz 0.1 cream topical corticosteroidmetaz 0.1 cream topical corticosteroid

http://buy-steroids.org